Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 4, 2026, 7:42 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 841–864 of 1,723 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Physical Activity Level Clear all

Conditions: Dizziness
Interventions: standard balance rehabilitation, gaze stability, Control; Behavioral
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 50 Years and older
Enrollment: 49 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2017
U.S. locations: 2
States / cities: Decatur, Georgia • Mountain Home, Tennessee

Conditions: HIV Infection, Fatigue
Interventions: Behavioral Activation Counseling; Behavioral
Lead sponsor: New York State Psychiatric Institute; Other
Eligibility: 18 Years to 70 Years
Enrollment: 138 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2019
U.S. locations: 2
States / cities: New York, New York

Conditions: Vascular Diseases, Surgery
Interventions: Protein-Calorie Restriction; Dietary Supplement
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years and older
Enrollment: 19 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Depression
Interventions: PROJECT PERSONALITY, VR PERSONALITY PROJECT, SHARING FEELINGS PROGRAM; Behavioral
Lead sponsor: Stony Brook University; Other
Eligibility: 12 Years to 16 Years
Enrollment: 159 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Stony Brook, New York

Conditions: Aging
Interventions: VM @ Home Usability; Behavioral
Lead sponsor: Northeastern University; Other
Eligibility: 65 Years and older
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2019
U.S. locations: 2
States / cities: Dedham, Massachusetts • Weston, Massachusetts

Conditions: Diabetes Mellitus, Overweight, Obesity
Interventions: NNC0487-0111, Placebo (matched to NNC0487-0111); Drug
Lead sponsor: Novo Nordisk A/S; Industry
Eligibility: 18 Years and older
Enrollment: 630 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 15
States / cities: Birmingham, Alabama • Escondido, California • Lomita, California + 12 more

Conditions: Uveal Melanoma
Interventions: Selumetinib, 100mg, Selumetinib, 125mg, Selumetinib, 150mg, Selumetinib, 175mg, Selumetinib, 200mg, Selumetinib, 225mg; Drug
Lead sponsor: Shaheer A. Khan; Other
Eligibility: 18 Years and older
Enrollment: 42 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2020
U.S. locations: 3
States / cities: New York, New York • Houston, Texas

Conditions: PreDiabetes, Older Adult, Muscle Loss, Muscle Weakness
Interventions: Vivo; Behavioral
Lead sponsor: Impactiv, Inc.; Industry
Eligibility: 60 Years and older
Enrollment: 74 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Cognitive Decline
Interventions: Behavioral Treatment; Behavioral
Lead sponsor: Pennington Biomedical Research Center; Other
Eligibility: 60 Years and older
Enrollment: 11 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025
U.S. locations: 1
States / cities: Baton Rouge, Louisiana

Conditions: Urinary Incontinence
Interventions: patient acceptable symptom state (PASS); Behavioral
Lead sponsor: University of Rochester; Other
Eligibility: 18 Years and older · Female only
Enrollment: 125 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Rochester, New York

Conditions: Invasive Mould Infection
Interventions: EL219, Active Comparator- IV Antifungal (LAmB or voriconazole); Drug
Lead sponsor: Elion Therapeutics, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026
U.S. locations: 11
States / cities: Birmingham, Alabama • Sacramento, California • Augusta, Georgia + 7 more

Conditions: Acquired Hemophilia A
Interventions: OBI-1; Biological
Lead sponsor: Baxalta now part of Shire; Industry
Eligibility: 18 Years and older
Enrollment: 29 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2013
U.S. locations: 8
States / cities: Indianapolis, Indiana • New Orleans, Louisiana • Bethesda, Maryland + 4 more

Conditions: COPD, OSA
Interventions: Exercise; Behavioral
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: Not listed
Enrollment: 28 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: Salem, Virginia

Conditions: Aging, Vascular Endothelium, Skeletal Muscle
Interventions: Step Count Reduction; Behavioral
Lead sponsor: University of Utah; Other
Eligibility: 18 Years and older
Enrollment: 14 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Hemodialysis
Interventions: Novel Physical Activity Program, Standard of Care Physical Activity Program; Behavioral
Lead sponsor: University of Illinois at Urbana-Champaign; Other
Eligibility: 18 Years and older
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023
U.S. locations: 3
States / cities: Bolingbrook, Illinois • Oak Brook, Illinois • Urbana, Illinois

Conditions: Multiple Sclerosis
Interventions: Social Support Program, Physical Activity Program, Physical Activity Plus Fatigue Management Education Program; Behavioral
Lead sponsor: Case Western Reserve University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 208 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2017
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Hypoxemia
Interventions: Capnography; Diagnostic Test
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 18 Years and older
Enrollment: 263 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2008
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Skin Cancer
Interventions: Education, Action Plan, UV Photo, MC1R Test; Behavioral
Lead sponsor: University of Utah; Other
Eligibility: 18 Years and older
Enrollment: 528 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Physical Activity
Interventions: Intervention Arm; Behavioral
Lead sponsor: Emory University; Other
Eligibility: Not listed
Enrollment: 4,968 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Lawrenceville, Georgia

Conditions: Metastatic Solid Tumors, Treatment-Refractory Cancers
Interventions: rhIL-15, Ipilimumab, Nivolumab, Tumor biopsies, EKG, ECHO, CT Scan; Drug · Procedure · Diagnostic Test
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 18 Years to 120 Years
Enrollment: 31 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2025
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Physical Inactivity, Poor Diet
Interventions: Brief Motivational Intervention, Educational information; Behavioral
Lead sponsor: University of Missouri-Columbia; Other
Eligibility: 18 Years and older
Enrollment: 70 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2009
U.S. locations: 1
States / cities: Memphis, Tennessee

Conditions: Mental Illness, Obesity
Interventions: MOVE!; Behavioral
Lead sponsor: US Department of Veterans Affairs; Federal
Eligibility: 18 Years to 75 Years
Enrollment: 109 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2011
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Breast Cancer Female
Interventions: Supervised Exercise, Home-based Exercise, Group Phone Calls, Diet; Behavioral
Lead sponsor: University of Kansas Medical Center; Other
Eligibility: Up to 71 Years · Female only
Enrollment: 11 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Kansas City, Kansas

Conditions: Healthy Volunteers
Interventions: CG100649 (2 mg), Celecoxib, Placebo capsules, Naproxen, Acetazolamide, CG100649 (8 mg); Drug
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years to 60 Years
Enrollment: 26 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2013
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Search by objective public record fields.

Vestibular Rehabilitation and Dizziness

Return to Work Randomized Controlled Trial: Counseling After Fatigue Treatment in HIV/AIDS

Dietary Restriction in Vascular Surgery

Building Evidence-Based Supports for Teens Via Technology

Integrated Web-Based Customer Engagement, Physical Exercise, and Coaching Platform for Older Adults

AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight

Intermittent Selumetinib for Uveal Melanoma

Examining the Effects of Vivo on Physical Function and Glycemic Level in Sedentary Older With Prediabetes.

Multicomponent Program for Addressing Cognition in Rural Communities

Patient Satisfaction Survey of Non-surgical Urinary Incontinence Treatment

Phase 2 EL219 Versus Liposomal Amphotericin B or Voriconazole for Early Antifungal Therapy

Study of Modified Recombinant Factor VIII (OBI-1) in Subjects With Acquired Hemophilia A

The Effect of Interval Exercise on Functional Outcomes in Veterans With COPD and OSA

Vascular Dysfunction During Physical Inactivity

Patient-Centered Physical Activity Program for Hemodialysis Patients

Examining the Effects of a Telehealth Self-management Intervention in Multiple Sclerosis

Does Capnography Prevent Hypoxemia During Endoscopic Retrograde Cholangiopancreatography and Endoscopic Ultrasound?

Undergraduate Skin Cancer Prevention Trial

A Rigorous Evaluation of the Relationship Between Physical Activity and Education Outcomes

Recombinant Interleukin-15 in Combination With Checkpoint Inhibitors Nivolumab and Ipilimumab in People With Refractory Cancers

Brief Motivational Intervention to Increase Physical Activity and Fruit/Vegetable Intake

Using MOVE! With Seriously Mentally Ill Veterans

Feasibility of High Levels of Energy Expenditure From Physical Activity for Breast Cancer Survivors

Effects of Dual Cyclooxygenase-2 and Carbonic Anhydrase Inhibition